EGFR and breast carcinoma: Interestingly, SHP-1 has also been reported to act as a tumor suppressor in breast cancer [32], and its expression is negatively correlated with EGFR (Epidermal growth factor receptor) [33], which is highly expressed in 15–45% of breast cancer [34].